Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evotec SE (EVO) Common Equity (2019 - 2025)

Historic Common Equity for Evotec SE (EVO) over the last 9 years, with Q3 2025 value amounting to $207825.3.

  • Evotec SE's Common Equity rose 658.13% to $207825.3 in Q3 2025 from the same period last year, while for Sep 2025 it was $207825.3, marking a year-over-year increase of 658.13%. This contributed to the annual value of $189732.3 for FY2024, which is 9998.43% down from last year.
  • As of Q3 2025, Evotec SE's Common Equity stood at $207825.3, which was up 658.13% from $201225.1 recorded in Q2 2025.
  • Evotec SE's Common Equity's 5-year high stood at $1.6 billion during Q4 2021, with a 5-year trough of $178417.2 in Q3 2022.
  • Moreover, its 5-year median value for Common Equity was $198601.0 (2022), whereas its average is $363.1 million.
  • In the last 5 years, Evotec SE's Common Equity surged by 8246.15% in 2021 and then crashed by 9998.43% in 2024.
  • Over the past 5 years, Evotec SE's Common Equity (Quarter) stood at $1.6 billion in 2021, then fell by 23.15% to $1.2 billion in 2022, then dropped by 0.52% to $1.2 billion in 2023, then tumbled by 99.98% to $189732.3 in 2024, then grew by 9.54% to $207825.3 in 2025.
  • Its Common Equity stands at $207825.3 for Q3 2025, versus $201225.1 for Q2 2025 and $186987.2 for Q1 2025.